MARKET

ALGS

ALGS

Aligos Therapeutics, Inc.
NASDAQ
40.80
+1.46
+3.70%
Opening 10:59 12/26 EST
OPEN
40.00
PREV CLOSE
39.34
HIGH
41.20
LOW
38.13
VOLUME
144.63K
TURNOVER
--
52 WEEK HIGH
42.95
52 WEEK LOW
6.76
MARKET CAP
146.37M
P/E (TTM)
-2.1821
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALGS last week (1216-1220)?
Weekly Report · 3d ago
Weekly Report: what happened at ALGS last week (1209-1213)?
Weekly Report · 12/16 09:19
ALIGOS THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 12/13 13:00
Tracking Baker Brothers Portfolio - Q3 2024 Update
Seeking Alpha · 12/12 04:38
Aligos Therapeutics: Promising Pipeline With Cash And Dilution Risks
Seeking Alpha · 12/11 13:09
Weekly Report: what happened at ALGS last week (1202-1206)?
Weekly Report · 12/09 09:18
Weekly Report: what happened at ALGS last week (1125-1129)?
Weekly Report · 12/02 09:18
Weekly Report: what happened at ALGS last week (1118-1122)?
Weekly Report · 11/25 09:17
More
About ALGS
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The Company discovers and develops therapeutics for metabolic dysfunction associated steatohepatitis (MASH) and viruses with high unmet medical need, such as chronic hepatitis B (CHB) and coronaviruses. Its advanced drug candidate for MASH is ALG-055009, a small molecule thyroid hormone receptor beta (THR-ß) agonist. It is also progressing oligonucleotide projects for MASH. It is developing a portfolio of differentiated CHB drug candidates, including a small molecule Capsid Assembly Modulator that results in the production of empty viral capsids (CAM-E) and small molecule inhibitors of the Programmed Cell Death Ligand 1 (PD-1/PD-L1) interaction. Its third area of focus is to develop drug candidates with pan-coronavirus antiviral activity. Its pipeline includes ALG-055009, ALG-000184, ALG-125755, and ALG-097558.

Webull offers Aligos Therapeutics Inc stock information, including NASDAQ: ALGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALGS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALGS stock methods without spending real money on the virtual paper trading platform.